According to the National Cancer Institute, invasive breast cancer affects approximately one in eight U.S. women, and about 5 percent to 10 percent of all breast cancers are hereditary.
At present, most people are familiar with BRCA1 and BRCA2 gene mutations, which are inherited gene mutations—or abnormalities in the DNA sequencing—that increase the risk of developing breast cancer.
According to statistics from the National Cancer Institute, by age 80, about 72% of women who’ve inherited a BRCA1 gene mutation and approximately 69% of women who’ve inherited a BRCA2 gene mutation will likely be diagnosed with breast cancer.
But this data only accounts for a small portion of women who will develop the disease. Are scientists any closer to determining additional genetic variants or factors that may play a role in the development of breast cancer? Actually, they are.
In October 2017, two studies were published in the journals Nature and Nature Genetics, respectively, which reported on the findings of 72 previously undiscovered gene mutations that increase a woman's risk of developing breast cancer. The international team, which conducted the studies, is called the OncoArray Consortium, and it brought together more than 500 researchers from over 300 institutions around the world—this study is being hailed as the most extensive breast cancer study in history.
To gather the information for this study, researchers analyzed the genetic data of 275,000 women—146,000 of whom had received a diagnosis of breast cancer. This vast collection of information is helping scientists identify new risk factors that predispose some women to breast cancer and may provide insights as to why certain types of cancers are more difficult to treat than others. Here are some of the specifics regarding this groundbreaking research:
Breastcancer.org, a non-profit organization committed to the mission of gathering information and creating a community for those affected by breast cancer, shares this information, “Most people who develop breast cancer have no family history of the disease. However, when a strong family history of breast and/or ovarian cancer is present, there may be reason to believe that a person has inherited an abnormal gene linked to higher breast cancer risk. Some people choose to undergo genetic testing to find out. A genetic test involves giving a blood or saliva sample that can be analyzed to pick up any abnormalities in these genes.”
Currently, the most common genetic tests for this disease are the BRCA1 and BRCA2 gene mutations. But as science introduces additional genetic variants linked to breast cancer, your healthcare provider may recommend further testing with a genetic counselor. If your personal or familial history suggests you could be a carrier of other genetic abnormalities, a more elaborate genetic panel may be of benefit to you. As advancements in the field of genetics continue, more accurate testing procedures will allow for earlier detection of breast cancer risk factors, a more individualized approach to care, and better treatment options.
Breastcancer.org recommends that women who are aware they have a genetic mutation linked to breast cancer consider implementing the following preventive measures to lessen the risk:
More aggressive preventative strategies may include:
Each woman’s family history is unique, so there’s no one-size-fits-all approach to preventing or treating hereditary breast cancer. If you’re at risk of developing hereditary breast cancer, be proactive and talk with your healthcare provider about how to best reduce your risk of the disease and, if necessary, the appropriate medical interventions available to you.
Should you find yourself facing the scary diagnosis of breast cancer, reach out to others for support. The breast cancer community is thriving, and it’s filled with some of the most resilient women you’ll ever meet. They'll encourage you on your journey. Plus, having the extra support can ease the feelings of isolation that may come about with a breast cancer diagnosis.